Infants and children receiving artificial heart-valve replacements face several repeat operations as they grow, since the replacements become too small and must be traded for bigger ones. Researchers at Children's Hospital Boston have now developed a solution: living, growing valves created in the lab from a patient's own cells.
Ads by Google
A new book of pocket-charts that will help health workers to identify people at risk of heart attacks and strokes.
Global Cardio Care Centers and its board-certified cardiologists and internal medicine physicians deliver pioneering enhanced external counterpulsation, or EECP providing FDA-approved treatment is first and foremost for people with congestive heart failure, coronary artery disease and angina.
Researchers said that women with heart conditions might need different treatments than men.
A potential new biomarker for heart failure may be more powerful than established measures in identifying patients at increased risk for death from several causes.
Researchers have discovered a treatment that counteracts the effects of cocaine on the human cardiovascular system, including lowering the elevated heart rate and blood pressure often found in cocaine users.
Health Canada is reviewing new preliminary safety information regarding serious cardiac events in patients using Losec and Nexium.
Abbott Laboratories enrolled the first patient in a clinical trial studying experimental drug-eluting heart stent device Xience
AcelleRX received funds to prepare for a Phase I clinical trial of its Stromal Derived Factor-1 as a treatment for chronic heart failure.
Ohio State University Medical Center has installed a machine that adds precision, safety and increased effectiveness to the catheter-based treatment of irregular heartbeats.
American Heart Association's San Antonio Division held an educational forum that addressed Hispanics increased risk for cardiovascular disease and the need to increase awareness
Researchers have successfully increased the number cells required for the normal development of right-sided structures in the heart.
Patients with heart failure who have low to low-normal serum potassium levels are at increased risk of death.
Three hospitals in Texas, Minnesota and Indiana informed to have 30 days to submit plans to overhaul their heart transplant programs or risk losing Medicare funding.
Cardica have entered into an agreement to develop and commercialize a specialized device designed to close the patent foramen ovale, a relatively common heart defect present in approximately 15 to 20 percent of the general population.
Oak Lawn-based Advocate Christ Medical Center will begin performing heart transplants, as a result of approval by the Illinois Health Facilities Planning Board.
Response Biomedical has been granted a medical device license by Health Canada to market its RAMPO NT-proBNP Test.
By uncovering how one breast cancer drug protects the heart and another does not, researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Standards for the use of ultrasound as a screening tool to measure narrowing of the carotid artery may be too aggressive, resulting in some needless follow-up tests and procedures.
Cardiac surgery death rates have dropped to their lowest level since the New Jersey Department of Health and Senior Services began issuing reports a decade ago.
GlaxoSmithKline confirms that a letter to the editor summarizing additional Avandia cardiovascular safety data from several large-scale clinical trials was published online today in The Lancet.
Rush University Medical Center and 2 BigHearts are offering a free women's heart screening on June 2, from 7 a.m. to 3 p.m. in Suite 1159 of the Rush Professional Building.